Indian Immunologicals launches pediatric dose of India ' s first Indigenous Hepatitis A vaccine
Indian Immunologicals Limited ( IIL ) has introduced a pediatric dose ( 0.5 ml ) of Havisure , India ’ s first indigenous Hepatitis A vaccine , advancing efforts to combat this contagious liver infection , especially in children . Vaccination remains the most effective way to prevent the disease .
Dr . K . Anand Kumar , Managing Director of IIL , emphasized , “ IIL is the single largest contributor to the self-sufficiency of vaccines in the country , this launch is a testament to IIL ’ s unwavering dedication to innovation and public health . IIL ’ s endeavor to make Indigenous vaccines will give the necessary impetus to “ Make in India ” efforts .”
To mark the launch , IIL organized free vaccination drives for children at two Hyderabad orphanages and hosted a health awareness session at an old age home . IIL is the only company in India to offer an indigenous Hepatitis A vaccine in both pediatric and adult doses .
BioTech
Indian Immunologicals launches needle-free intra-nasal booster vaccine for COVID-19
ZIndian Immunologicals Limited ( IIL ) has announced the development of a live-attenuated , needle-free intra-nasal booster vaccine for SARS-CoV-2 , created using codon deoptimization technology in collaboration with Griffith University , Australia . This breakthrough was published in Nature Communications on August 26 , 2024 .
The vaccine demonstrated strong stability and safety in animal studies and generates a broad neutralizing antibody response . Codon deoptimization efficiently attenuates viruses by modifying genetic sequences , making it faster and safer than traditional methods .
BIOVOICENEWS . COM 09